ICanPlay Pilot Study: Tailoring a Remote-Based Physical Activity Intervention for Children Ages 4-12 Years Undergoing Cancer Treatment Read more
A randomized phase 3 trial of fludarabine/cytarabine/gemtuzumab ozogamicin with or without venetoclax in children with relapsed AML Read more
Elucidating the Pediatric Solid Tumor Microenvironment to Correlate with Response to Therapy and for the Development of Biomarkers and Patient-derived Cell Models Read more
A Phase I Study of 2-Hydroxyoleic Acid in Pediatric Patients with Malignant Glioma and Other Advanced Solid Tumors Read more
ISCADOR® P (MISTLETOE) IMMUNOTHERAPY TO IMPROVE EVENT FREE SURVIVAL IN OSTEOSARCOMA PATIENTS WITH PULMONARY METASTASES Read more
